Hap Trading, LLC Abb Vie Inc. Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $321,984 - $362,629	2,340 Added 12.86%	20,530 $3.18 Billion
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $507,775 - $587,824	-3,801 Reduced 17.28%	18,190 $2.71 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $3.61 Million - $4.49 Million	-27,243 Reduced 55.33%	21,991 $2.96 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $7.12 Million - $8.2 Million	49,234 New	49,234 $7.85 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.46 Million - $1.68 Million	10,882 New	10,882 $1.46 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $4.18 Million - $4.65 Million	-39,690 Reduced 72.07%	15,380 $1.73 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $2.23 Million - $2.46 Million	21,824 Added 65.64%	55,070 $5.96 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $281,795 - $380,453	3,501 Added 11.77%	33,246 $3.56 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $1.13 Million - $1.32 Million	13,112 Added 78.83%	29,745 $2.61 Million
Q2 2020 Aug 10, 2020	SELL	$73.37 - $98.18 $564,362 - $755,200	-7,692 Reduced 31.62%	16,633 $1.63 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $619,909 - $939,859	9,611 Added 65.32%	24,325 $1.85 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $831,947 - $1.04 Million	-11,534 Reduced 43.94%	14,714 $1.3 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $529,279 - $676,542	8,056 Added 44.28%	26,248 $1.91 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $578,472 - $680,834	7,499 Added 70.13%	18,192 $1.47 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $832,450 - $1.03 Million	10,693 New	10,693 $986,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account